文献速递心力衰竭与心肌病

骨桥蛋白通过线粒体途径促进左室舒张功能障碍

Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

该研究在射血分数保留的心力衰竭(HFpEF)患者心肌、人诱导多能干细胞衍生心肌细胞及Col4a3-/-小鼠模型中探索骨桥蛋白(OPN)的作用。发现HFpEF患者心肌OGDHL表达异常,阻断OPN可提高OGDHL表达;Col4a3-/-小鼠表现出类似HFpEF的心肌病,敲除Opn或心脏过表达Ogdhl可改善心脏功能。提示OPN与OGDHL是慢性肾脏病相关HFpEF的潜在治疗靶点。

要点

  • HFpEF患者心肌OGDHL mRNA和蛋白表达异常。
  • Col4a3-/-小鼠重现HFpEF样心肌病,敲除Opn可改善。
  • 心脏特异性过表达Ogdhl改善Col4a3-/-小鼠心脏功能。

核心结论

  • Col4a3-/-小鼠是慢性肾脏病继发HFpEF的模型,OPN与OGDHL是其中间环节并可能作为治疗靶点。

研究设计与样本

  • 研究定量了HFpEF、射血分数降低的心力衰竭及供体对照心肌样本中OGDHL mRNA和蛋白。
  • 在有无抗OPN抗体处理的人诱导多能干细胞衍生心肌细胞中定量OGDHL表达。
  • 在Col4a3-/-小鼠中评估了全局Opn敲除或AAV9介导心脏递送Ogdhl对心脏参数的影响。

主要发现

  • HFpEF患者(n=17)心肌OGDHL mRNA和蛋白丰度异常,与供体对照(n=12;p<0.01)或射血分数降低的心力衰竭患者(n=12;p<0.05)相比。
  • 在hiPS-CMs中阻断OPN可增加OGDHL表达。
  • Col4a3-/-小鼠表现出类似HFpEF的心肌病,包括舒张功能障碍、心肌肥厚和纤维化、肺水肿及线粒体功能受损。
  • Opn-/-可改善该心肌病,同时肾功能改善且Ogdhl表达增加。
  • 心脏特异性过表达Ogdhl也可改善Col4a3-/-小鼠心脏功能及心肌细胞能量状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with chronic kidney disease (CKD) and coincident heart failure with preserved ejection fraction (HFpEF) may constitute a distinct HFpEF phenotype. Osteopontin (OPN) is a biomarker of HFpEF and predictive of disease outcome. We recently reported that OPN blockade reversed hypertension, mitochondrial dysfunction, and kidney failure in Col4a3-/- mice, a model of human Alport syndrome. OBJECTIVES: The purpose of this study was to identify potential OPN targets in biopsies of HF patients, healthy control subjects, and human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs), and to characterize the cardiac phenotype of Col4a3-/- mice, relate this to HFpEF, and investigate possible causative roles for OPN in driving the cardiomyopathy. METHODS: OGDHL mRNA and protein were quantified in myocardial samples from patients with HFpEF, heart failure with reduced ejection fraction, and donor control subjects. OGDHL expression was quantified in hiPS-CMs treated with or without anti-OPN antibody. Cardiac parameters were evaluated in Col4a3-/- mice with and without global OPN knockout or AAV9-mediated delivery of 2-oxoglutarate dehydrogenase-like (Ogdhl) to the heart. RESULTS: OGDHL mRNA and protein displayed abnormal abundances in cardiac biopsies of HFpEF (n = 17) compared with donor control subjects (n = 12; p < 0.01) or heart failure with reduced ejection fraction patients (n = 12; p < 0.05). Blockade of OPN in hiPS-CMs conferred increased OGDHL expression. Col4a3-/- mice demonstrated cardiomyopathy with similarities to HFpEF, including diastolic dysfunction, cardiac hypertrophy and fibrosis, pulmonary edema, and impaired mitochondrial function. The cardiomyopathy was ameliorated by Opn-/- coincident with improved renal function and increased expression of Ogdhl. Heart-specific overexpression of Ogdhl in Col4a3-/- mice also improved cardiac function and cardiomyocyte energy state. CONCLUSIONS: Col4a3-/- mice present a model of HFpEF secondary to CKD wherein OPN and OGDHL are intermediates, and possibly therapeutic targets.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Yousefi K, Irion CI, Takeuchi LM, et al. Osteopontin Promotes Left Ventricular Diastolic Dysfunction Through a Mitochondrial Pathway. J Am Coll Cardiol. 2019. PMID: 31146816. doi:10.1016/j.jacc.2019.02.074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。